Instituto do Cancer do Estado de São Paulo ICESP

São Paulo 01246-000

1 studies enrolling now · 5 studies all time

What they study most

Advanced Cutaneous Squamous Cell Carcinoma, Anaplastic Lymphoma Kinase-positive, Leiomyosarcoma, Metastatic Adenocarcinoma of the Pancreas, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Oral Cavity

Studies at this site

• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment — Completed
• A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) — Stopped early
• Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma — Completed
• IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity — Completed